ArticleBMC cancer2024

Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma.

Yongqiang Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.